Alpha7 Nicotine Acetylcholine Receptor Agonist PNU-282987 Attenuates Acute Lung Injury in a Cardiopulmonary Bypass Model in Rats
- PMID: 27661000
- DOI: 10.1097/SHK.0000000000000744
Alpha7 Nicotine Acetylcholine Receptor Agonist PNU-282987 Attenuates Acute Lung Injury in a Cardiopulmonary Bypass Model in Rats
Abstract
Objective: Cardiopulmonary bypass (CPB) carries a risk of lung ischemia-reperfusion, leading to acute lung injury (ALI). Alpha7 nicotinic acetylcholine receptor (alpha7nAChR) has been implicated in the release of high mobility group box1 (HMGB1), which promotes systemic inflammation in response to ischemia-reperfusion injury. However, the specific role of alpha7nAChR in CPB is poorly understood. This study employed the alpha7nAChR agonist PNU-282987 and a rat model of CPB to determine whether alpha7nAChR was associated with CPB-induced lung damage.
Methods: Thirty Sprague-Dawley rats were randomly divided into five groups as follows: normal group, sham group, CPB group, PNU-282987 plus CPB group, and PNU-282987 plus sham group. Rats were subjected to CPB under anesthesia for 60 min. PNU-282987 (4.8 mg/kg) was administered via arterial inflow. Two hours post-CPB, samples of blood, bronchoalveolar lavage fluid (BALF), and lung tissues were processed for investigations.
Results: In CPB rats, structural damage in the lung was marked. Density of alpha7nAChR of the lung in the CPB group was significantly less than all other groups, while lung edema, inflammatory markers in serum and lung, protein concentrations in BALF were significantly higher. In the PNU-282987 plus CPB group, by all the above measures the CPB-associated effects were significantly ameliorated but were not identical to the control groups.
Conclusion: Our results suggest that PNU-282987 affords protective effect against CPB-induced ALI, and inhibits HMGB1 release.
Similar articles
-
Electroacupuncture Pretreatment Attenuates Acute Lung Injury Through α7 Nicotinic Acetylcholine Receptor-Mediated Inhibition of HMGB1 Release in Rats After Cardiopulmonary Bypass.Shock. 2018 Sep;50(3):351-359. doi: 10.1097/SHK.0000000000001050. Shock. 2018. PMID: 29117064 Free PMC article.
-
Alpha7 nicotinic acetylcholine receptor activation attenuated intestine-derived acute lung injury.J Surg Res. 2016 Apr;201(2):258-65. doi: 10.1016/j.jss.2015.10.046. Epub 2015 Nov 6. J Surg Res. 2016. PMID: 27020805
-
Acute lung injury is reduced by the α7nAChR agonist PNU-282987 through changes in the macrophage profile.FASEB J. 2017 Jan;31(1):320-332. doi: 10.1096/fj.201600431R. Epub 2016 Oct 11. FASEB J. 2017. PMID: 27729414
-
Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation.Rev Endocr Metab Disord. 2020 Dec;21(4):431-447. doi: 10.1007/s11154-020-09584-3. Epub 2020 Aug 26. Rev Endocr Metab Disord. 2020. PMID: 32851581 Free PMC article. Review.
-
Lung injury after cardiopulmonary bypass: Alternative treatment prospects.World J Clin Cases. 2022 Jan 21;10(3):753-761. doi: 10.12998/wjcc.v10.i3.753. World J Clin Cases. 2022. PMID: 35127892 Free PMC article. Review.
Cited by
-
Revisiting the Cardioprotective Effects of Acetylcholine Receptor Activation against Myocardial Ischemia/Reperfusion Injury.Int J Mol Sci. 2018 Aug 21;19(9):2466. doi: 10.3390/ijms19092466. Int J Mol Sci. 2018. PMID: 30134547 Free PMC article. Review.
-
Activation of Nicotinic Acetylcholine α7 Receptor Attenuates Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats by Downregulating the NLRP3 Inflammasome.Front Pharmacol. 2019 Feb 26;10:128. doi: 10.3389/fphar.2019.00128. eCollection 2019. Front Pharmacol. 2019. PMID: 30863307 Free PMC article.
-
Muscularis macrophages: Key players in intestinal homeostasis and disease.Cell Immunol. 2018 Aug;330:142-150. doi: 10.1016/j.cellimm.2017.12.009. Epub 2017 Dec 26. Cell Immunol. 2018. PMID: 29291892 Free PMC article. Review.
-
The Cholinergic Pathways in Inflammation: A Potential Pharmacotherapeutic Target for COPD.Front Pharmacol. 2018 Dec 3;9:1426. doi: 10.3389/fphar.2018.01426. eCollection 2018. Front Pharmacol. 2018. PMID: 30559673 Free PMC article. Review.
-
α7 Nicotinic Agonist AR-R17779 Protects Mice against 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis in a Spleen-Dependent Way.Front Pharmacol. 2017 Nov 8;8:809. doi: 10.3389/fphar.2017.00809. eCollection 2017. Front Pharmacol. 2017. PMID: 29167641 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources